Royal Bank of Canada »

Crescent Biopharma shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $0 20 0.00
2025-06-30 $0 20 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Crescent Biopharma

Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Vestal Point Capital
FMR
BVF
Opaleye Management
Tang Capital Management
ADAR1 Capital Management
Logos Global Management
Vanguard Group
Perceptive Advisors
Deep Track Capital
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma